Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ESMO Congress 2026 · Barcelona, Spain
200 shown of 2,355 total abstracts
  1. Abstract 91182026-09-04 · 20:45 CT · S406
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-737
    J. Cortes, G. Curigliano · UCSF Helen Diller Family Comprehensive Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  2. Abstract 91602026-09-05 · 16:45 CT · S100A
    Real-world effectiveness of Tagrisso vs standard of care in NSCLC
    M. Reck, R. Herbst, F. Andre, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  3. Abstract 96672026-09-04 · 20:00 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-219
    S. Peters, T. Mok, M. Reck, et al. · Cleveland Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  4. Abstract 95802026-09-02 · 14:45 CT · Arie Crown Theater
    Real-world effectiveness of Tecentriq vs standard of care in NSCLC
    S. Peters, R. Herbst, C. Saura, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  5. Abstract 92162026-09-02 · 20:00 CT · S100A
    Real-world effectiveness of Enhertu vs standard of care in NSCLC
    F. Andre, T. Mok, H. Borghaei, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  6. Abstract 92842026-09-02 · 15:15 CT · S406
    FLAURA-115: Tagrisso (osimertinib) 3L+ in NSCLC
    N. Rizvi, M. Reck, M.C. Garassino, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  7. Abstract 90482026-09-02 · 20:30 CT · Hall B1
    FLAURA-659: Tagrisso (osimertinib) 3L+ in NSCLC
    S. Peters, C. Saura, S. Modi, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  8. Abstract 94892026-09-03 · 20:15 CT · S100A
    Real-world effectiveness of Imfinzi vs standard of care in SCLC
    M. Reck, G. Curigliano, P. Schmid · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  9. Abstract 97402026-09-05 · 20:00 CT · Arie Crown Theater
    PACIFIC-876: Imfinzi (durvalumab) 3L+ in SCLC
    T. Mok, F. Andre, H. Borghaei, et al. · Princess Margaret Cancer Centre
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  10. Abstract 97842026-09-02 · 13:15 CT · S406
    Real-world effectiveness of Imfinzi vs standard of care in NSCLC
    P. Schmid, L. Paz-Ares · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  11. Abstract 93612026-09-03 · 16:45 CT · Hall B1
    FLAURA-47: Tagrisso (osimertinib) maintenance in NSCLC
    E. Winer, C. Robert · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  12. Abstract 90062026-09-03 · 18:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-267 study)
    S. Modi, C. Robert · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  13. Abstract 90962026-09-05 · 14:30 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-358 study)
    H. Borghaei, C. Saura, S. Tolaney, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  14. Abstract 98102026-09-04 · 19:30 CT · S406
    FLAURA-600: Tagrisso (osimertinib) neoadjuvant in NSCLC
    H. Borghaei, M. Reck, R. Herbst, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  15. Abstract 93522026-09-02 · 15:30 CT · S100A
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-269 study)
    F. Andre, T. Mok · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  16. Abstract 94202026-09-02 · 18:45 CT · Hall B1
    Quality of life outcomes with Tagrisso in patients with NSCLC
    M.C. Garassino, E. Winer, H. Rugo, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  17. Abstract 90032026-09-05 · 18:45 CT · S100A
    KEYNOTE-751: Keytruda (pembrolizumab) 3L+ in SCLC
    A. Spira, C. Robert · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Small Cell📄🖼️
  18. Abstract 91232026-09-05 · 18:15 CT · E450
    PACIFIC-784: Imfinzi (durvalumab) 2L in NSCLC
    H. Rugo, N. Rizvi · Chinese University of Hong Kong
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  19. Abstract 95002026-09-01 · 13:15 CT · Hall B1
    Quality of life outcomes with Enhertu in patients with NSCLC
    M. Krop, J. Cortes, S. Peters, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  20. Abstract 94792026-09-05 · 19:30 CT · Arie Crown Theater
    Long-term follow-up of Opdivo 3L+ for NSCLC: CheckMate-472
    M. Reck, H. Borghaei, L. Paz-Ares · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  21. Abstract 95532026-09-04 · 19:00 CT · S100A
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-713 study)
    P. Schmid, S. Modi, S. Peters, et al. · Mayo Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  22. Abstract 98322026-09-02 · 15:00 CT · Hall B1
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-909 study)
    C. Saura, L. Paz-Ares, M.C. Garassino, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  23. Abstract 97182026-09-02 · 18:15 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-552
    L. Paz-Ares, M. Krop, J. Brahmer · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  24. Abstract 95562026-09-01 · 15:45 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-866
    N. Rizvi, H. Borghaei, M. Krop, et al. · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  25. Abstract 91892026-09-05 · 14:00 CT · Hall B1
    Long-term follow-up of Tecentriq 2L for NSCLC: IMpower-504
    M. Reck, M. Krop, G. Curigliano, et al. · Vall d'Hebron Institute of Oncology
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  26. Abstract 95962026-09-01 · 13:30 CT · Arie Crown Theater
    Long-term follow-up of Keytruda adjuvant for SCLC: KEYNOTE-670
    M. Krop, M. Reck, L. Paz-Ares, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  27. Abstract 92442026-09-02 · 21:15 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-552
    A. Spira, H. Borghaei, S. Modi, et al. · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  28. Abstract 96082026-09-01 · 14:15 CT · Arie Crown Theater
    PACIFIC-694: Imfinzi (durvalumab) 1L in SCLC
    M. Reck, M.C. Garassino, C. Robert · Chinese University of Hong Kong
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  29. Abstract 99352026-09-05 · 21:00 CT · S100A
    Quality of life outcomes with Keytruda in patients with SCLC
    S. Peters, H. Borghaei, P. Schmid, et al. · Princess Margaret Cancer Centre
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  30. Abstract TPS80292026-09-04 · 18:45 CT · Hall B1
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-883
    S. Tolaney, C. Robert, A. Spira · Massachusetts General Hospital
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  31. Abstract 92442026-09-02 · 19:15 CT · S100A
    KEYNOTE-523: Keytruda (pembrolizumab) adjuvant in SCLC
    A. Spira, R. Herbst, H. Borghaei · Massachusetts General Hospital
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  32. Abstract 91612026-09-01 · 20:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-991 study)
    M. Reck, C. Saura · Cleveland Clinic
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  33. Abstract 93722026-09-01 · 19:30 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-907 study)
    M. Krop, M.C. Garassino, M. Reck, et al. · National Cancer Center Japan
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  34. Abstract 92642026-09-02 · 13:45 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-159 study)
    M.C. Garassino, G. Curigliano, H. Rugo, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  35. Abstract 90982026-09-01 · 14:15 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-126 study)
    N. Rizvi, R. Herbst, E. Winer · National Cancer Center Japan
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  36. Abstract e120352026-09-03 · 21:15 CT · E450
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-797 study)
    H. Borghaei, F. Andre · Dana-Farber Cancer Institute
    Publication OnlyLung Cancer—Small Cell📄🖼️
  37. Abstract LBA4036LBA2026-09-03 · 20:30 CT · Arie Crown Theater
    PACIFIC-122: Imfinzi (durvalumab) 1L in SCLC
    N. Rizvi, S. Antonia, M. Reck · University of Chicago
    Late-Breaking Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  38. Abstract 90652026-09-04 · 14:00 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-871 study)
    L. Paz-Ares, M. Krop, H. Rugo, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  39. Abstract 90452026-09-03 · 18:15 CT · S406
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-245 study)
    M. Reck, C. Saura, M.C. Garassino, et al. · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  40. Abstract 93622026-09-04 · 18:00 CT · Arie Crown Theater
    Long-term follow-up of Enhertu 2L for NSCLC: DESTINY-Breast-841
    H. Rugo, C. Saura · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  41. Abstract 90382026-09-04 · 21:30 CT · S406
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-494 study)
    E. Winer, S. Antonia, J. Cortes · MD Anderson Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  42. Abstract 93142026-09-05 · 14:30 CT · Arie Crown Theater
    Long-term follow-up of Keytruda adjuvant for SCLC: KEYNOTE-709
    F. Andre, S. Modi, P. Schmid · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Small Cell📄🖼️
  43. Abstract 96232026-09-03 · 16:30 CT · S100A
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-679 study)
    T. Mok, S. Peters, R. Herbst, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  44. Abstract e120432026-09-02 · 16:15 CT · S406
    Long-term follow-up of Opdivo 2L for NSCLC: CheckMate-629
    N. Rizvi, H. Borghaei, S. Modi, et al. · Karolinska Institute
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  45. Abstract 99262026-09-04 · 20:30 CT · S406
    FLAURA-358: Tagrisso (osimertinib) adjuvant in NSCLC
    J. Cortes, N. Rizvi, H. Borghaei, et al. · National Cancer Center Japan
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  46. Abstract e120452026-09-03 · 15:00 CT · E450
    Real-world effectiveness of Opdivo vs standard of care in NSCLC
    M. Reck, M.C. Garassino, L. Paz-Ares · Cleveland Clinic
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  47. Abstract LBA4046LBA2026-09-02 · 19:30 CT · S100A
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-5 study)
    C. Robert, G. Curigliano, L. Paz-Ares, et al. · Institut Gustave Roussy
    Late-Breaking Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  48. Abstract 95092026-09-05 · 18:45 CT · S100A
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-952
    S. Tolaney, S. Modi, G. Curigliano, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  49. Abstract 92942026-09-04 · 18:45 CT · Arie Crown Theater
    Long-term follow-up of Enhertu neoadjuvant for NSCLC: DESTINY-Breast-388
    M. Krop, L. Paz-Ares, R. Herbst, et al. · Massachusetts General Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  50. Abstract 95832026-09-04 · 15:00 CT · Hall B1
    PACIFIC-592: Imfinzi (durvalumab) 3L+ in NSCLC
    A. Spira, P. Schmid, J. Brahmer, et al. · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  51. Abstract 90262026-09-02 · 19:00 CT · S100A
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-236
    N. Rizvi, A. Spira, J. Brahmer, et al. · Stanford Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  52. Abstract 91512026-09-02 · 19:15 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-137
    H. Rugo, M. Krop, M.C. Garassino · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  53. Abstract 97742026-09-05 · 13:30 CT · E450
    KEYNOTE-117: Keytruda (pembrolizumab) adjuvant in NSCLC
    S. Peters, M.C. Garassino · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  54. Abstract e120532026-09-01 · 14:00 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-353
    H. Borghaei, F. Andre, S. Antonia, et al. · Chinese University of Hong Kong
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  55. Abstract 99152026-09-05 · 20:30 CT · S406
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-330
    J. Cortes, F. Andre, S. Modi, et al. · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  56. Abstract 96522026-09-03 · 16:45 CT · S100A
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-854
    M. Reck, S. Modi · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  57. Abstract 96922026-09-04 · 18:15 CT · E450
    Quality of life outcomes with Imfinzi in patients with NSCLC
    S. Tolaney, P. Schmid · Mayo Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  58. Abstract 98682026-09-03 · 21:45 CT · S406
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-667
    P. Schmid, C. Robert, N. Rizvi · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  59. Abstract 92372026-09-04 · 21:30 CT · E450
    Quality of life outcomes with Tecentriq in patients with NSCLC
    H. Borghaei, T. Mok, S. Modi, et al. · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  60. Abstract 99292026-09-04 · 13:00 CT · Hall B1
    KEYNOTE-735: Keytruda (pembrolizumab) 3L+ in NSCLC
    S. Peters, M.C. Garassino, J. Brahmer · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  61. Abstract 96532026-09-04 · 20:15 CT · E450
    FLAURA-665: Tagrisso (osimertinib) 2L in NSCLC
    L. Paz-Ares, N. Rizvi, A. Spira, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  62. Abstract 94102026-09-04 · 13:45 CT · S406
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-641
    R. Herbst, S. Peters, P. Schmid, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  63. Abstract 93192026-09-03 · 13:45 CT · E450
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-688
    T. Mok, H. Rugo · Karolinska Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  64. Abstract 96602026-09-01 · 20:30 CT · S100A
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-520 study)
    C. Saura, R. Herbst, E. Winer, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  65. Abstract 97742026-09-04 · 18:30 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-436
    S. Antonia, A. Spira, M.C. Garassino, et al. · University of Chicago
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  66. Abstract 90452026-09-02 · 13:15 CT · Hall B1
    Long-term follow-up of Keytruda 1L for NSCLC: KEYNOTE-397
    G. Curigliano, J. Cortes, J. Brahmer, et al. · Peter MacCallum Cancer Centre
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  67. Abstract 91342026-09-03 · 13:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-406 study)
    C. Robert, H. Borghaei, J. Cortes · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  68. Abstract 94582026-09-01 · 13:30 CT · S100A
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-857 study)
    N. Rizvi, H. Rugo, C. Robert · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  69. Abstract 91052026-09-02 · 21:30 CT · S100A
    DESTINY-Breast-800: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    C. Saura, A. Spira · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  70. Abstract 96592026-09-04 · 16:45 CT · E450
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-773
    M. Reck, N. Rizvi, P. Schmid · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  71. Abstract 98452026-09-02 · 21:00 CT · S406
    Long-term follow-up of Keytruda 3L+ for SCLC: KEYNOTE-639
    M.C. Garassino, A. Spira · Cleveland Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  72. Abstract 97472026-09-01 · 18:00 CT · S406
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-522 study)
    M. Krop, G. Curigliano · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  73. Abstract LBA4072LBA2026-09-05 · 15:45 CT · E450
    Long-term follow-up of Imfinzi maintenance for SCLC: PACIFIC-689
    M. Reck, S. Peters · Stanford Cancer Institute
    Plenary SessionLung Cancer—Small Cell📄🖼️
  74. Abstract e120732026-09-03 · 18:45 CT · E450
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-487 study)
    J. Cortes, T. Mok, J. Brahmer, et al. · Memorial Sloan Kettering Cancer Center
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  75. Abstract 94042026-09-01 · 20:45 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-633
    S. Peters, E. Winer, S. Modi, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  76. Abstract 96622026-09-03 · 21:45 CT · Arie Crown Theater
    Enhertu plus chemotherapy in previously untreated NSCLC: updated analysis from DESTINY-Breast-925
    H. Borghaei, S. Antonia · University of Chicago
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  77. Abstract 97652026-09-04 · 21:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-985 study)
    C. Robert, E. Winer, F. Andre, et al. · Dana-Farber Cancer Institute
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  78. Abstract 97742026-09-04 · 15:45 CT · S406
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-306
    C. Saura, P. Schmid, M.C. Garassino, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  79. Abstract 90092026-09-01 · 19:45 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-853 study)
    C. Saura, S. Antonia, H. Rugo · University of Chicago
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  80. Abstract 95502026-09-01 · 19:30 CT · Hall B1
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-271 study)
    S. Tolaney, E. Winer, P. Schmid · Chinese University of Hong Kong
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  81. Abstract 95122026-09-03 · 20:15 CT · E450
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-642
    F. Andre, L. Paz-Ares · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  82. Abstract 95322026-09-04 · 18:45 CT · S406
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-956 study)
    S. Peters, S. Modi, C. Saura · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  83. Abstract 91992026-09-01 · 16:30 CT · S406
    FLAURA-802: Tagrisso (osimertinib) adjuvant in NSCLC
    E. Winer, S. Tolaney, A. Spira, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  84. Abstract 91692026-09-04 · 13:30 CT · Hall B1
    PACIFIC-331: Imfinzi (durvalumab) 3L+ in SCLC
    L. Paz-Ares, J. Cortes · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  85. Abstract 98702026-09-02 · 18:45 CT · Arie Crown Theater
    KEYNOTE-584: Keytruda (pembrolizumab) 2L in SCLC
    S. Tolaney, M.C. Garassino · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  86. Abstract 92492026-09-05 · 16:00 CT · E450
    Long-term follow-up of Imfinzi maintenance for NSCLC: PACIFIC-49
    L. Paz-Ares, J. Brahmer, C. Robert, et al. · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  87. Abstract 90912026-09-02 · 21:30 CT · S406
    Long-term follow-up of Imfinzi maintenance for SCLC: PACIFIC-412
    T. Mok, L. Paz-Ares · Massachusetts General Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  88. Abstract 92722026-09-05 · 19:30 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-520
    H. Rugo, R. Herbst, S. Modi, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  89. Abstract 94032026-09-01 · 18:30 CT · S406
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-144
    H. Rugo, M. Krop · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  90. Abstract 95572026-09-02 · 14:00 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-386
    N. Rizvi, S. Peters, M. Reck, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  91. Abstract 94782026-09-02 · 19:00 CT · S406
    KEYNOTE-192: Keytruda (pembrolizumab) 1L in NSCLC
    M. Reck, A. Spira, H. Borghaei · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  92. Abstract 98852026-09-01 · 20:30 CT · E450
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-969
    G. Curigliano, M.C. Garassino, H. Borghaei, et al. · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  93. Abstract 94472026-09-04 · 18:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-747 study)
    S. Antonia, R. Herbst, J. Brahmer, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  94. Abstract 90982026-09-01 · 16:00 CT · S406
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-289
    E. Winer, J. Cortes, S. Peters, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  95. Abstract 95152026-09-01 · 15:00 CT · E450
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-763 study)
    C. Robert, F. Andre, P. Schmid · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  96. Abstract 93052026-09-04 · 15:45 CT · S406
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-573
    M.C. Garassino, H. Rugo, H. Borghaei, et al. · University of Chicago
    Clinical Science SymposiumLung Cancer—Small Cell📄🖼️
  97. Abstract 95412026-09-04 · 21:00 CT · E450
    FLAURA-992: Tagrisso (osimertinib) maintenance in NSCLC
    J. Cortes, S. Peters, H. Rugo, et al. · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  98. Abstract 96372026-09-02 · 18:15 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi adjuvant for NSCLC: PACIFIC-432
    R. Herbst, P. Schmid · University of Chicago
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  99. Abstract 97992026-09-01 · 18:15 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-383
    H. Borghaei, C. Robert, L. Paz-Ares, et al. · Peter MacCallum Cancer Centre
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  100. Abstract 90892026-09-05 · 20:30 CT · S100A
    Quality of life outcomes with Keytruda in patients with NSCLC
    E. Winer, H. Rugo · Massachusetts General Hospital
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  101. Abstract e121002026-09-04 · 14:00 CT · Hall B1
    PACIFIC-298: Imfinzi (durvalumab) 3L+ in NSCLC
    N. Rizvi, M.C. Garassino, H. Rugo, et al. · Dana-Farber Cancer Institute
    Publication OnlyLung Cancer—Non-Small Cell Metastatic📄🖼️
  102. Abstract 96502026-09-04 · 21:15 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-134
    M.C. Garassino, H. Rugo, T. Mok, et al. · Peter MacCallum Cancer Centre
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  103. Abstract 93472026-09-01 · 21:30 CT · Arie Crown Theater
    Long-term follow-up of Tecentriq 1L for NSCLC: IMpower-318
    N. Rizvi, S. Peters, C. Robert · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  104. Abstract 90912026-09-04 · 19:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-348 study)
    N. Rizvi, E. Winer, M. Reck · MD Anderson Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  105. Abstract 90692026-09-02 · 13:15 CT · Arie Crown Theater
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-381
    P. Schmid, E. Winer, L. Paz-Ares, et al. · Vall d'Hebron Institute of Oncology
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  106. Abstract 97292026-09-05 · 16:30 CT · S406
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-678
    P. Schmid, M.C. Garassino · Peter MacCallum Cancer Centre
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  107. Abstract 91452026-09-05 · 18:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-678 study)
    R. Herbst, N. Rizvi · Stanford Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  108. Abstract 96352026-09-03 · 13:15 CT · Hall B1
    PACIFIC-140: Imfinzi (durvalumab) 2L in NSCLC
    S. Antonia, J. Cortes, L. Paz-Ares, et al. · Johns Hopkins Kimmel Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  109. Abstract 98782026-09-02 · 14:45 CT · Hall B1
    Quality of life outcomes with Opdivo in patients with NSCLC
    N. Rizvi, L. Paz-Ares, M. Krop · Princess Margaret Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  110. Abstract 97872026-09-03 · 16:15 CT · Hall B1
    DESTINY-Breast-469: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    J. Brahmer, F. Andre, L. Paz-Ares, et al. · Vall d'Hebron Institute of Oncology
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  111. Abstract LBA4110LBA2026-09-03 · 14:15 CT · S100A
    Long-term follow-up of Imfinzi 2L for NSCLC: PACIFIC-115
    R. Herbst, E. Winer, H. Borghaei, et al. · University of Chicago
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  112. Abstract 98822026-09-01 · 19:30 CT · Arie Crown Theater
    IMpower-559: Tecentriq (atezolizumab) 3L+ in NSCLC
    A. Spira, C. Saura, H. Rugo, et al. · Institut Gustave Roussy
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  113. Abstract e121122026-09-03 · 16:45 CT · S406
    PACIFIC-447: Imfinzi (durvalumab) maintenance in SCLC
    E. Winer, M.C. Garassino, J. Cortes · Institut Gustave Roussy
    Publication OnlyLung Cancer—Small Cell📄🖼️
  114. Abstract 94982026-09-02 · 14:30 CT · S100A
    Biomarker subgroup analysis of Keytruda in NSCLC (the KEYNOTE-861 study)
    C. Robert, G. Curigliano, N. Rizvi · National Cancer Center Japan
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  115. Abstract 91522026-09-02 · 14:15 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi 2L for SCLC: PACIFIC-922
    J. Cortes, S. Antonia, N. Rizvi, et al. · Institut Gustave Roussy
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  116. Abstract 95742026-09-03 · 18:15 CT · S100A
    Long-term follow-up of Imfinzi 1L for SCLC: PACIFIC-953
    S. Tolaney, C. Robert, E. Winer, et al. · Chinese University of Hong Kong
    Poster SessionLung Cancer—Small Cell📄🖼️
  117. Abstract 98732026-09-01 · 14:15 CT · E450
    Quality of life outcomes with Imfinzi in patients with SCLC
    C. Saura, L. Paz-Ares, A. Spira, et al. · Karolinska Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  118. Abstract 92792026-09-04 · 19:45 CT · S100A
    FLAURA-921: Tagrisso (osimertinib) neoadjuvant in NSCLC
    P. Schmid, G. Curigliano, L. Paz-Ares · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  119. Abstract 98872026-09-01 · 19:00 CT · S406
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-618
    M. Krop, S. Peters, H. Borghaei, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  120. Abstract 99072026-09-05 · 18:00 CT · E450
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-60
    P. Schmid, C. Robert · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  121. Abstract 97282026-09-01 · 20:30 CT · Hall B1
    DESTINY-Breast-470: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    J. Cortes, C. Robert, J. Brahmer, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  122. Abstract 98632026-09-02 · 13:15 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-215
    C. Robert, P. Schmid, R. Herbst, et al. · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  123. Abstract 99442026-09-02 · 20:45 CT · S100A
    CheckMate-311: Opdivo (nivolumab) 2L in NSCLC
    N. Rizvi, G. Curigliano · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  124. Abstract 99822026-09-04 · 18:00 CT · Hall B1
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-681
    M. Reck, L. Paz-Ares, T. Mok, et al. · Memorial Sloan Kettering Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  125. Abstract 95992026-09-01 · 19:45 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-224 study)
    T. Mok, E. Winer · Cleveland Clinic
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  126. Abstract 91372026-09-04 · 21:00 CT · Arie Crown Theater
    CheckMate-953: Opdivo (nivolumab) neoadjuvant in NSCLC
    E. Winer, H. Borghaei, S. Peters, et al. · Dana-Farber Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  127. Abstract 91022026-09-01 · 19:15 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-531 study)
    S. Peters, R. Herbst, S. Tolaney, et al. · National Cancer Center Japan
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  128. Abstract 97432026-09-04 · 13:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-36 study)
    C. Saura, N. Rizvi, S. Modi, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  129. Abstract 97172026-09-02 · 20:30 CT · E450
    Long-term follow-up of Enhertu adjuvant for NSCLC: DESTINY-Breast-496
    C. Saura, T. Mok, F. Andre, et al. · Memorial Sloan Kettering Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  130. Abstract 96972026-09-02 · 21:15 CT · Arie Crown Theater
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-967
    G. Curigliano, A. Spira, S. Modi, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  131. Abstract LBA4130LBA2026-09-03 · 18:30 CT · E450
    Long-term follow-up of Opdivo adjuvant for NSCLC: CheckMate-860
    R. Herbst, S. Tolaney, S. Antonia · Princess Margaret Cancer Centre
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  132. Abstract 95102026-09-05 · 13:15 CT · S406
    Long-term follow-up of Imfinzi neoadjuvant for SCLC: PACIFIC-377
    M. Krop, H. Borghaei · Royal Marsden Hospital
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  133. Abstract 95022026-09-05 · 21:00 CT · S406
    KEYNOTE-447: Keytruda (pembrolizumab) 1L in SCLC
    S. Peters, H. Rugo, M.C. Garassino, et al. · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  134. Abstract 93952026-09-04 · 13:45 CT · Arie Crown Theater
    FLAURA-529: Tagrisso (osimertinib) 2L in NSCLC
    C. Saura, P. Schmid, L. Paz-Ares · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  135. Abstract 95432026-09-05 · 13:45 CT · S406
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-385 study)
    J. Brahmer, T. Mok · National Cancer Center Japan
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  136. Abstract 93622026-09-04 · 19:45 CT · S406
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-240
    S. Peters, H. Borghaei, S. Tolaney, et al. · Karolinska Institute
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  137. Abstract 95192026-09-02 · 19:00 CT · Arie Crown Theater
    KEYNOTE-852: Keytruda (pembrolizumab) maintenance in SCLC
    L. Paz-Ares, H. Borghaei, F. Andre, et al. · University of Chicago
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  138. Abstract TPS81372026-09-05 · 18:45 CT · S406
    FLAURA-546: Tagrisso (osimertinib) adjuvant in NSCLC
    H. Rugo, M. Reck, J. Cortes · University of Chicago
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  139. Abstract 93532026-09-01 · 20:00 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in SCLC
    T. Mok, S. Modi, M. Krop, et al. · Stanford Cancer Institute
    Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  140. Abstract 96412026-09-01 · 21:30 CT · Arie Crown Theater
    Long-term follow-up of Imfinzi 1L for SCLC: PACIFIC-995
    J. Cortes, A. Spira · MD Anderson Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  141. Abstract TPS81402026-09-05 · 14:15 CT · Hall B1
    Long-term follow-up of Imfinzi 3L+ for SCLC: PACIFIC-676
    M.C. Garassino, G. Curigliano, M. Reck · University of Chicago
    Trials in Progress Poster SessionLung Cancer—Small Cell📄🖼️
  142. Abstract 90122026-09-02 · 16:45 CT · E450
    FLAURA-944: Tagrisso (osimertinib) neoadjuvant in NSCLC
    S. Modi, M.C. Garassino · Memorial Sloan Kettering Cancer Center
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  143. Abstract e121422026-09-05 · 21:00 CT · E450
    Long-term follow-up of Imfinzi neoadjuvant for SCLC: PACIFIC-539
    C. Robert, N. Rizvi, J. Cortes · MD Anderson Cancer Center
    Publication OnlyLung Cancer—Small Cell📄🖼️
  144. Abstract 98282026-09-01 · 21:00 CT · S406
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-937
    M. Krop, M. Reck, T. Mok, et al. · Royal Marsden Hospital
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  145. Abstract 96452026-09-02 · 18:45 CT · S100A
    Biomarker subgroup analysis of Imfinzi in NSCLC (the PACIFIC-604 study)
    H. Rugo, M. Reck, C. Saura · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  146. Abstract 93352026-09-05 · 19:30 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated NSCLC: updated analysis from KEYNOTE-508
    M. Krop, G. Curigliano, T. Mok, et al. · Peter MacCallum Cancer Centre
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  147. Abstract 90872026-09-01 · 15:30 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-348
    S. Tolaney, S. Peters, S. Modi, et al. · Mayo Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  148. Abstract 95172026-09-03 · 15:15 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-995
    G. Curigliano, J. Cortes · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  149. Abstract 94562026-09-04 · 20:15 CT · Arie Crown Theater
    KEYNOTE-437: Keytruda (pembrolizumab) adjuvant in SCLC
    C. Robert, A. Spira, C. Saura, et al. · Karolinska Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  150. Abstract 96172026-09-04 · 16:30 CT · Arie Crown Theater
    Real-world effectiveness of Keytruda vs standard of care in NSCLC
    H. Rugo, S. Tolaney, M.C. Garassino · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  151. Abstract 97852026-09-04 · 16:45 CT · Hall B1
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-53 study)
    M. Krop, L. Paz-Ares, S. Peters, et al. · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  152. Abstract 94322026-09-03 · 14:00 CT · Arie Crown Theater
    FLAURA-481: Tagrisso (osimertinib) adjuvant in NSCLC
    J. Cortes, P. Schmid · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  153. Abstract 90562026-09-02 · 15:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-503 study)
    J. Brahmer, M. Reck, E. Winer, et al. · National Cancer Center Japan
    Poster SessionLung Cancer—Small Cell📄🖼️
  154. Abstract 90602026-09-04 · 13:00 CT · S100A
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-789 study)
    E. Winer, N. Rizvi · Chinese University of Hong Kong
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  155. Abstract 97052026-09-03 · 18:15 CT · S100A
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-977
    L. Paz-Ares, S. Peters, G. Curigliano, et al. · Memorial Sloan Kettering Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  156. Abstract 96192026-09-05 · 15:45 CT · S100A
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-830
    F. Andre, T. Mok · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  157. Abstract LBA4156LBA2026-09-01 · 15:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-605 study)
    H. Rugo, G. Curigliano, S. Tolaney, et al. · Stanford Cancer Institute
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  158. Abstract 93862026-09-03 · 13:45 CT · E450
    Long-term follow-up of Keytruda maintenance for NSCLC: KEYNOTE-976
    C. Saura, J. Brahmer, C. Robert, et al. · Karolinska Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  159. Abstract 97382026-09-05 · 16:30 CT · S100A
    DESTINY-Breast-568: Enhertu (trastuzumab deruxtecan) maintenance in NSCLC
    H. Rugo, J. Brahmer, J. Cortes · Johns Hopkins Kimmel Cancer Center
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  160. Abstract 99992026-09-01 · 13:00 CT · Hall B1
    Long-term follow-up of Opdivo neoadjuvant for NSCLC: CheckMate-404
    S. Antonia, C. Robert · Peter MacCallum Cancer Centre
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  161. Abstract 93312026-09-03 · 13:00 CT · S100A
    PACIFIC-832: Imfinzi (durvalumab) 2L in NSCLC
    S. Tolaney, J. Brahmer, S. Modi, et al. · MD Anderson Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  162. Abstract 92342026-09-02 · 21:30 CT · S406
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-860
    C. Robert, M.C. Garassino, R. Herbst, et al. · Cleveland Clinic
    Poster SessionLung Cancer—Small Cell📄🖼️
  163. Abstract 91272026-09-05 · 20:00 CT · S406
    KEYNOTE-527: Keytruda (pembrolizumab) neoadjuvant in NSCLC
    S. Antonia, S. Tolaney · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  164. Abstract 98982026-09-04 · 18:00 CT · Hall B1
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-518
    M. Reck, S. Antonia · Karolinska Institute
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  165. Abstract 92692026-09-02 · 13:30 CT · S406
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-310
    E. Winer, G. Curigliano, A. Spira, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  166. Abstract LBA4165LBA2026-09-03 · 20:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-392 study)
    M.C. Garassino, J. Cortes · Vall d'Hebron Institute of Oncology
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  167. Abstract 90962026-09-02 · 14:15 CT · Arie Crown Theater
    Opdivo plus chemotherapy in previously untreated NSCLC: updated analysis from CheckMate-657
    T. Mok, J. Brahmer, C. Saura, et al. · Chinese University of Hong Kong
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  168. Abstract LBA4167LBA2026-09-02 · 16:00 CT · Arie Crown Theater
    Long-term follow-up of Opdivo neoadjuvant for NSCLC: CheckMate-420
    H. Borghaei, C. Saura, L. Paz-Ares, et al. · Stanford Cancer Institute
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  169. Abstract TPS81682026-09-04 · 16:15 CT · S100A
    FLAURA-1: Tagrisso (osimertinib) 1L in NSCLC
    P. Schmid, N. Rizvi, A. Spira, et al. · Memorial Sloan Kettering Cancer Center
    Trials in Progress Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  170. Abstract 93272026-09-05 · 15:15 CT · Arie Crown Theater
    Biomarker subgroup analysis of Tagrisso in NSCLC (the FLAURA-603 study)
    S. Modi, S. Antonia · Institut Gustave Roussy
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  171. Abstract 98512026-09-03 · 21:00 CT · S100A
    Long-term follow-up of Tagrisso 1L for NSCLC: FLAURA-263
    J. Cortes, M. Krop, F. Andre · Mayo Clinic
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  172. Abstract 94642026-09-05 · 13:30 CT · E450
    Biomarker subgroup analysis of Enhertu in NSCLC (the DESTINY-Breast-267 study)
    S. Antonia, H. Rugo, S. Peters, et al. · Massachusetts General Hospital
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  173. Abstract 99552026-09-03 · 21:15 CT · S100A
    Biomarker subgroup analysis of Tecentriq in NSCLC (the IMpower-60 study)
    T. Mok, M. Reck, S. Antonia, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  174. Abstract e121732026-09-03 · 21:45 CT · S100A
    Imfinzi plus chemotherapy in previously untreated SCLC: updated analysis from PACIFIC-319
    S. Antonia, G. Curigliano, C. Saura, et al. · Vall d'Hebron Institute of Oncology
    Publication OnlyLung Cancer—Small Cell📄🖼️
  175. Abstract 96902026-09-05 · 20:00 CT · Hall B1
    Long-term follow-up of Tagrisso adjuvant for NSCLC: FLAURA-502
    H. Rugo, E. Winer · Peter MacCallum Cancer Centre
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  176. Abstract 94282026-09-01 · 21:15 CT · Hall B1
    Biomarker subgroup analysis of Keytruda in SCLC (the KEYNOTE-459 study)
    C. Robert, A. Spira, S. Tolaney, et al. · Johns Hopkins Kimmel Cancer Center
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  177. Abstract 97572026-09-05 · 14:15 CT · E450
    DESTINY-Breast-445: Enhertu (trastuzumab deruxtecan) 3L+ in NSCLC
    G. Curigliano, F. Andre, M. Reck, et al. · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  178. Abstract 93592026-09-03 · 21:30 CT · Hall B1
    KEYNOTE-541: Keytruda (pembrolizumab) 1L in SCLC
    C. Robert, R. Herbst, E. Winer, et al. · Royal Marsden Hospital
    Poster SessionLung Cancer—Small Cell📄🖼️
  179. Abstract 92452026-09-05 · 19:00 CT · Arie Crown Theater
    Keytruda plus chemotherapy in previously untreated SCLC: updated analysis from KEYNOTE-751
    N. Rizvi, J. Brahmer, T. Mok · Johns Hopkins Kimmel Cancer Center
    Poster SessionLung Cancer—Small Cell📄🖼️
  180. Abstract 92992026-09-01 · 21:45 CT · Hall B1
    DESTINY-Breast-28: Enhertu (trastuzumab deruxtecan) neoadjuvant in NSCLC
    C. Saura, H. Borghaei, M. Krop, et al. · Massachusetts General Hospital
    Education SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  181. Abstract 90732026-09-02 · 16:30 CT · S406
    IMpower-509: Tecentriq (atezolizumab) adjuvant in NSCLC
    A. Spira, S. Tolaney · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  182. Abstract 91202026-09-01 · 18:15 CT · S100A
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-842
    C. Saura, J. Brahmer · Karolinska Institute
    Clinical Science SymposiumLung Cancer—Non-Small Cell Metastatic📄🖼️
  183. Abstract 95102026-09-04 · 15:15 CT · S406
    Long-term follow-up of Keytruda 2L for SCLC: KEYNOTE-949
    J. Brahmer, E. Winer, S. Antonia · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Small Cell📄🖼️🎬
  184. Abstract 99612026-09-01 · 18:15 CT · S406
    Imfinzi plus chemotherapy in previously untreated NSCLC: updated analysis from PACIFIC-950
    P. Schmid, M. Reck · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  185. Abstract 90142026-09-02 · 18:30 CT · Hall B1
    Long-term follow-up of Tagrisso 2L for NSCLC: FLAURA-994
    J. Brahmer, F. Andre, E. Winer, et al. · MD Anderson Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  186. Abstract 90332026-09-01 · 21:15 CT · E450
    Long-term follow-up of Imfinzi 2L for NSCLC: PACIFIC-58
    M.C. Garassino, C. Saura, S. Modi · Memorial Sloan Kettering Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  187. Abstract 92242026-09-01 · 18:45 CT · S406
    Long-term follow-up of Tagrisso 3L+ for NSCLC: FLAURA-114
    M. Krop, L. Paz-Ares · Royal Marsden Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  188. Abstract 97002026-09-02 · 18:45 CT · E450
    Long-term follow-up of Opdivo maintenance for NSCLC: CheckMate-510
    S. Peters, A. Spira, H. Borghaei · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  189. Abstract 98492026-09-03 · 13:15 CT · Arie Crown Theater
    Long-term follow-up of Tagrisso neoadjuvant for NSCLC: FLAURA-284
    E. Winer, H. Borghaei, G. Curigliano, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  190. Abstract LBA4189LBA2026-09-05 · 21:45 CT · Arie Crown Theater
    KEYNOTE-989: Keytruda (pembrolizumab) neoadjuvant in NSCLC
    G. Curigliano, H. Rugo, E. Winer · University of Chicago
    Plenary SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  191. Abstract 92882026-09-01 · 20:30 CT · Hall B1
    Biomarker subgroup analysis of Imfinzi in SCLC (the PACIFIC-413 study)
    C. Robert, M.C. Garassino, A. Spira · Karolinska Institute
    Poster Discussion SessionLung Cancer—Small Cell📄🖼️
  192. Abstract 95492026-09-03 · 14:00 CT · S406
    KEYNOTE-828: Keytruda (pembrolizumab) maintenance in SCLC
    E. Winer, S. Antonia · Dana-Farber Cancer Institute
    Poster SessionLung Cancer—Small Cell📄🖼️
  193. Abstract 91432026-09-03 · 19:30 CT · Arie Crown Theater
    Biomarker subgroup analysis of Opdivo in NSCLC (the CheckMate-237 study)
    M. Krop, C. Saura, F. Andre, et al. · Institut Gustave Roussy
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  194. Abstract 98752026-09-03 · 19:00 CT · Arie Crown Theater
    IMpower-759: Tecentriq (atezolizumab) maintenance in NSCLC
    S. Antonia, P. Schmid, F. Andre, et al. · Stanford Cancer Institute
    Poster Discussion SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  195. Abstract 93402026-09-04 · 21:30 CT · S100A
    DESTINY-Breast-739: Enhertu (trastuzumab deruxtecan) neoadjuvant in NSCLC
    S. Tolaney, S. Peters · UCSF Helen Diller Family Comprehensive Cancer Center
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  196. Abstract 98962026-09-03 · 18:00 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-861
    H. Rugo, J. Cortes, H. Borghaei, et al. · Vall d'Hebron Institute of Oncology
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  197. Abstract 98882026-09-01 · 18:15 CT · E450
    Tecentriq plus chemotherapy in previously untreated NSCLC: updated analysis from IMpower-224
    T. Mok, J. Cortes · Cleveland Clinic
    Rapid Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  198. Abstract 96072026-09-01 · 20:30 CT · Arie Crown Theater
    DESTINY-Breast-389: Enhertu (trastuzumab deruxtecan) adjuvant in NSCLC
    H. Rugo, T. Mok, N. Rizvi, et al. · Massachusetts General Hospital
    Poster SessionLung Cancer—Non-Small Cell Metastatic📄🖼️
  199. Abstract LBA4198LBA2026-09-02 · 14:30 CT · E450
    Tagrisso plus chemotherapy in previously untreated NSCLC: updated analysis from FLAURA-53
    H. Borghaei, R. Herbst, M. Krop · National Cancer Center Japan
    Late-Breaking Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
  200. Abstract 99282026-09-04 · 15:30 CT · E450
    Long-term follow-up of Tecentriq maintenance for NSCLC: IMpower-923
    M.C. Garassino, M. Reck, R. Herbst · Royal Marsden Hospital
    Oral Abstract SessionLung Cancer—Non-Small Cell Metastatic📄🖼️🎬
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.